Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
68(c) 68.27(c) 69.08(c) 68.89(c) 68.3 Last
4 287 950 3 938 399 7 379 827 3 987 378 4 419 017 Volume
+0.53% +0.40% +1.19% -0.28% -0.86% Change
More quotes
Financials ($)
Sales 2015 15 353 M
EBIT 2015 3 263 M
Net income 2015 2 845 M
Finance 2015 1 784 M
Yield 2015 2,16%
Sales 2016 16 492 M
EBIT 2016 4 246 M
Net income 2016 3 779 M
Finance 2016 2 349 M
Yield 2016 2,27%
PER 2015 45,26
PER 2016 30,05
EV / Sales 2015 7,36x
EV / Sales 2016 6,82x
Capitalization 114 838 M
More Financials
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
07/23Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
07:33a BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion in the European Union for ..
02:53a BRISTOL MYERS SQUIBB : to Present Data on Its Immuno-Oncology Agents at ASCO Eve..
05/20 BRISTOL MYERS SQUIBB : New Pharmacokinetics Study Results from Bristol-Myers Squ..
05/20 BRISTOL MYERS SQUIBB : Research Results from Bristol-Myers Squibb Update Underst..
05/20 BRISTOL MYERS SQUIBB : New Peptides and Proteins Data Have Been Reported by Inve..
05/20 BRISTOL MYERS SQUIBB : Receives Amended U.S. FDA Breakthrough Therapy Designatio..
05/19 BRISTOL MYERS SQUIBB : Eric Stonestreet, of Television’s Hit Comedy, &ldqu..
05/18 BRISTOL MYERS SQUIBB : to Present Data on Its Immuno-Oncology Agents at ASCO Eve..
More news
Sector news : Pharmaceuticals - NEC
05:29p AMGEN : ends work on experimental psoriasis drug
05:26pDJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca
05:13p TSX eases after recent rally as energy, financials slip
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04:00p SEEKING ALPHA'S BIOTECH WEEKLY : J&J-Achillion Vs. Gilead, MannKind's Marketing,..
08:57a Merck gets EU green light for Keytruda
05/20 FDA amends Bristol-Myers' BTD tag for HCV-1 candidate
05/19 REPATRIATION HOLIDAY : Past, Present, And The Companies That Will Benefit In The..
05/18 The Battle Of The Bulge


Comments 
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions